Chemotherapy is treatment of cancer with anticancer drugs. Chemotherapy is administered in different ways, depending on the drugs to be given and the type of cancer. Doctors decide the dose of chemotherapy drugs considering many factors, among them being the patient’s height and weight.
‘Mini’ stem cell transplantation may reverse severe sickle cell disease – Results of a preliminary study by scientists at the National Institutes of Health and Johns Hopkins show that “mini” stem cell transplantation may safely reverse severe sickle cell disease in adults.
Women fare better than men with metastatic colorectal cancer — are hormones helping? – Younger women with metastatic colorectal cancer lived longer than younger men, revealed by researchers in a new US study. However, this survival advantage disappeared with age, suggesting a benefit from estrogen or other hormones.
Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy – For the first time researchers have shown that by inhibiting the action of an enzyme called TAK-1, it is possible to make pancreatic cancer cells sensitive to chemotherapy, opening the way for the development of a new drug to treat the disease.
Stem cell ‘daughters’ lead to breast cancer — Breast cells are likely to be responsible for breast cancers. – Breast cells called luminal progenitor cells are likely to be responsible for breast cancers that develop in women carrying mutations in the gene BRCA1, revealed by researchers.
Surgery remans an option for advanced lung cancer after standard chemotherapy and radiation. – Surgery after standard chemotherapy and radiation can be an option for lung cancer patients, revealed by researchers in new study published in the Lancet.
Cancer Center Studies Lead to New Trials for Malignant Melanoma Treatment — Breast cancer drug Abraxane promising for metastatic malignant melanoma treatment. – An approved breast-cancer drug nab-paclitaxel, trade named Abraxane, has been found promising in clinical trial for the treatment of metastatic malignant melanoma, revealed by researchers.
JNCI news brief: Thalidomide does not improve survival in small cell lung cancer – Treating patients with thalidomide in combination with chemotherapy for small cell lung cancer (SCLC) did not improve their survival but did increase their risk of blood clots, revealed by researchers.
ASTRO issues consensus statement on using APBI to treat breast cancer – A new consensus statement outlining patient selection criteria and best practices for the use of accelerated partial breast irradiation (APBI) outside the context of a clinical trial has been published in the July 15 issue of the International Journal of Radiation Oncology Biology Physics.
New technique could save cancer patients’ fertility — Researchers grow immature human egg cells to nearly mature egg in laboratory. – Researchers have successfully grown a woman’s immature egg cells, contained in a tiny sac called a follicle, to a healthy and nearly mature egg in the laboratory. When an egg is fully mature, it is ready to be fertilized.
Researchers find genetic key to breast cancer’s ability to survive and spread – New research led by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) sheds light on a genetic function that gives breast cancer cells the ability to survive and spread to the bone years after treatment has been administered.
U.S. Food and Drug Administration (FDA) approves first maintenance drug therapy for advanced lung cancer — Alimta, pemetrexed. – Eli Lilly’s lung cancer drug Alimta (pemetrexed) — the first drug available for maintenance therapy of advanced or metastatic lung cancer, is approved by the U.S. Food and Drug Administration, USA.
A new weapon in the war against HIV-AIDS: Combined antiviral and targeted chemotherapy – HIV-AIDS could be treated through a combination of targeted chemotherapy and current Highly Active Retroviral (HAART) treatments, revealed by researchers.
